Cargando…

Can proton pump inhibitors cause intestinal inflammation in children?

Detalles Bibliográficos
Autor principal:	Kang, Ben
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Pediatric Society 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801195/ https://www.ncbi.nlm.nih.gov/pubmed/31623419 http://dx.doi.org/10.3345/kjp.2019.00878

Ejemplares similares

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Can Nocturnal Acid-breakthrough Be Reduced by Long-acting Proton Pump Inhibitors?
por: Jeon, Hye Kyung, et al.
Publicado: (2017)

Risk of Pyogenic Liver Abscess in Proton Pump Inhibitor Users: New Inventory of Proton Pump Inhibitor Induced Complications?
por: Bang, Ki Bae
Publicado: (2021)

Proton Pump Inhibitor-associated Mucosal Change
por: Kato, Mototsugu, et al.
Publicado: (2017)

Proton pump inhibitors in the COVID-19 pandemic()
por: Sebastián Domingo, Juan J.
Publicado: (2021)

Can Esophageal Baseline Impedance Predict Proton Pump Inhibitor Response in Gastroesophageal Reflux Disease?
por: Jung, Kyoungwon, et al.
Publicado: (2018)

H(2) antagonists, proton pump inhibitors and COVID-19
por: Hirota, Kazuyoshi
Publicado: (2022)

The Complex Interaction between Proton Pump Inhibitors and Cancer Treatment
por: Chen, Hao, et al.
Publicado: (2023)

Influence of proton pump inhibitor therapy on intestinal inflammation assessed by fecal calprotectin in pediatric patients
por: Kim, Su Yeong, et al.
Publicado: (2019)

Risk of small intestinal bacterial overgrowth in patients receiving proton pump inhibitors versus proton pump inhibitors plus prokinetics
por: Revaiah, Pruthvi C, et al.
Publicado: (2018)

Proton Pump Inhibitor-Responsive Esophageal Eosinophilia: Controversies and Its Clinical Implications
por: Shin, Cheol Min, et al.
Publicado: (2016)

Protons pump inhibitor treatment and lower gastrointestinal bleeding: Balancing risks and benefits
por: Lué, Alberto, et al.
Publicado: (2016)

Failure of optimized dual proton pump inhibitor amoxicillin therapy: What now?
por: Graham, David Y., et al.
Publicado: (2017)

Proton pump inhibitors and adverse kidney outcomes during immune checkpoint blockade: time to sound the alarm?
por: Tan, Hui Zhuan, et al.
Publicado: (2023)

Are proton pump inhibitors a double-edged sword in the treatment of Helicobacter pylori infection?
por: Ge, Ruiguang
Publicado: (2012)

Does Long-Term Proton Pump Inhibitor Therapy Affect the Health of Gut Microbiota?
por: Lee, Chansu, et al.
Publicado: (2016)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

ODP116 Proton Pump Inhibitor Induced Hypocalcemia - An Overlooked Cause
por: Rivera, Krystal, et al.
Publicado: (2022)

Impedance pH Guided Approach to Proton Pump Inhibitor-refractory Non-erosive Reflux Disease
por: Cho, Yu Kyung
Publicado: (2014)

Do Proton Pump Inhibitor–refractory Laryngeal Symptoms Represent a True Acid-related Disease?
por: Hong, Kwon-Eui, et al.
Publicado: (2023)

How can proton pump inhibitors damage central and peripheral nervous systems?
por: Makunts, Tigran, et al.
Publicado: (2020)

Proton pump inhibitors may enhance the risk of digestive diseases by regulating intestinal microbiota
por: Tian, Liang, et al.
Publicado: (2023)

Non-Specific Gastric Inflammation in Children is Associated with Proton Pump Inhibitor Treatment for More than 6 Weeks
por: Rosas-Blum, Eduardo, et al.
Publicado: (2014)

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
por: Shin, Jai Moo, et al.
Publicado: (2013)

Proton pump inhibitors and hypomagnesemia monitoring
por: Lemon, Thomas I
Publicado: (2013)

Use and overuse of proton pump inhibitors
por: Staiano, Annamaria, et al.
Publicado: (2015)

Symptomatic hypomagnesemia and proton pump inhibitors
por: Tin, Sim Sai, et al.
Publicado: (2014)

Proton Pump Inhibitors Should be Used with Caution in Critically Ill Patients to Prevent the Risk of Clostridium difficile Infection
por: Min, Jung Hwa, et al.
Publicado: (2016)

A Narrative Review on Efficacy and Safety of Proton Pump Inhibitors in Children
por: Dipasquale, Valeria, et al.
Publicado: (2022)

Use of proton pump inhibitors in scandinavian children and adolescents: An observational study
por: Closs, Emilie Raaum, et al.
Publicado: (2023)

Proton Pump Inhibitor Use and Risk of Serious Infections in Young Children
por: Lassalle, Marion, et al.
Publicado: (2023)

Proton Pump Inhibitor Prophylaxis After Gastric Bypass Does Not Cause Hypomagnesemia
por: Boerlage, Thomas C. C., et al.
Publicado: (2016)

Pharmacoepidemiology for nephrologists: do proton pump inhibitors cause chronic kidney disease?
por: Tomlinson, Laurie A., et al.
Publicado: (2017)

The Perilous PPI: Proton Pump Inhibitor as a Cause of Clinically Significant Hypomagnesaemia
por: Tai, Yong Ting, et al.
Publicado: (2020)

Iron deficiency anemia from iron malabsorption caused by proton pump inhibitors
por: Boxer, Michael
Publicado: (2020)

Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis
por: Ghebremariam, Yohannes T, et al.
Publicado: (2015)

Is the Diagnostic Trial with Proton Pump Inhibitors Reasonable for School Age Children with Gastroesophageal Reflux Symptoms?
por: Yang, Jaeeun, et al.
Publicado: (2019)

Proton pump inhibitors induce hemolytic anemia
por: Al-Nasser, Asayil Nasser, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fm025dnqh370mmm91j13rpnfrs